Abiopharma

News list

Elkins David V 🔴 sold 56.0K shares of BRISTOL MYERS SQUIBB CO (BMY) at $47.33 ($2.7M) Transaction Date: Sep 02, 2025 | Filing ID: 000144

Full text

News bot Sept. 3, 2025, 10:47 p.m.
🔍 Elkins David V (Executive)

Company: BRISTOL MYERS SQUIBB CO (BMY)

Report Date: 2025-09-02
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 1
- Total shares sold: 56,000
- Total shares held: 283
Detailed Transactions and Holdings:
- Sold 56,000 shares of Common Stock, $0.10 par value at $47.33 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 167,379.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Holds 0 shares of Common Stock, $0.10 par value (Direct)
  Date: 2025-09-02 | Code: H | nature_of_ownership: BMS Savings and Investment Program | shares_owned_after: 283.40 | Footnotes: F3
Footnotes:
- F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2025.
- F2: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $47.075 to $47.820, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- F3: Based on recent 401(k) plan statement.
- REMARKS: EXHIBIT LIST: EX-24 Exhibit 24 - David V. Elkins, GRAPHIC Exhibit 24 - David V. Elkins